Latest news

Pahalgam attackers will be hunted down: Rajnath Singh

Pahalgam attackers will be hunted down: Rajnath Singh

Kulgam gunfight erupts after Pahalgam attack

Kulgam gunfight erupts after Pahalgam attack

Muslim Leaders Unite, Condemn Pahalgam Terror Attack

Muslim Leaders Unite, Condemn Pahalgam Terror Attack

Assam ensures the safe return of a family after the Pahalgam attack

Assam ensures the safe return of a family after the Pahalgam attack

Telangana sets up helpline post Pahalgam terror attack

Telangana sets up helpline post Pahalgam terror attack

Katra to Delhi special train service amid Pahalgam crisis

Katra to Delhi special train service amid Pahalgam crisis

Terror attack shatters peace In Telugu homes

Terror attack shatters peace In Telugu homes

The Pahalgam terror attack has led to a 90% drop in Kashmir tourism

The Pahalgam terror attack has led to a 90% drop in Kashmir tourism

Indian-American teen wins $25k for work on potential Covid-19 cure

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      A 14-year-old Indian-American girl has won a USD 25,000 young scientist challenge for a discovery that could provide a potential treatment for Covid-19.

      Anika Chebrolu, an eighth-grader from Texas, won the 3M Young Scientist Challenge, for her work on finding a molecule that can selectively bind to the spike protein of SARS-CoV-2 virus in an attempt to find a cure for the same, according to the 3M Challenge website.

      Chebrolu was one of the 10 finalists in this year’s 3M Young Scientist Challenge. In addition to the prize money, she was also awarded an exclusive 3M Mentorship.

      ADVERTISEMENT

      Up Next

      Indian-American teen wins $25k for work on potential Covid-19 cure

      Indian-American teen wins $25k for work on potential Covid-19 cure

      ADVERTISEMENT

      editorji-whatsApp
      Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.